Insulin: Discovery and Controversy

Abstract

During the first two decades of the 20th century, several investigators prepared extracts of pancreas that were often successful in lowering blood sugar and reducing glycosuria in test animals. However, they were unable to remove impurities, and toxic reactions prevented its use in humans with diabetes. In the spring of 1921, Frederick G. Banting, a young Ontario orthopedic surgeon, was given laboratory space by J.J.R. Macleod, the head of physiology at the University of Toronto, to investigate the function of the pancreatic islets. A student assistant, Charles Best, and an allotment of dogs were provided to test Banting’s hypothesis that ligation of the pancreatic ducts before extraction of the pancreas, destroys the enzyme-secreting parts, whereas the islets of Langerhans, which were believed to produce an internal secretion regulating sugar metabolism, remained intact. He believed that earlier failures were attributable to the destructive action of trypsin. The name “insuline” had been introduced in 1909 for this hypothetic substance. Their experiments produced an extract of pancreas that reduced the hyperglycemia and glycosuria in dogs made diabetic by the removal of their pancreases. They next developed a procedure for extraction from the entire pancreas without the need for duct ligation. This extract, now made from whole beef pancreas, was successful for treating humans with diabetes. Facilitating their success was a development in clinical chemistry that allowed blood sugar to be frequently and accurately determined in small volumes of blood. Success with purification was largely the work of J.B. Collip. Yield and standardization were improved by cooperation with Eli Lilly and Company. When the Nobel Prize was awarded to Banting and Macleod for the discovery of insulin, it aggravated the contentious relationship that had developed between them during the course of the investigation. Banting was outraged that Macleod and not Best had been selected, and he briefly threatened to refuse the award. He immediately announced that he was giving one-half of his share of the prize money to Best and publicly acknowledged Best’s contribution to the discovery of insulin. Macleod followed suit and gave one-half of his money award to Collip. Years later, the official history of the Nobel Committee admitted that Best should have been awarded a share of the prize.

Measuring insulin in human vitreous humour using LC‐MS/MS

“…With the discovery of insulin in 1921, its pharmaceutical production (from bovine and porcine pancreas and eventually by biotechnological methods) and introduction into medical therapy allowed numerous patients suffering from diabetes mellitus considerably improved conditions of living with a formerly mortal disease. [1] The facile availability of insulin proved to be both a blessing and a curse, since numerous suspected, purported, and evidenced murders by insulin have been reported. [2][3][4] Diagnosis of hyperinsulinemia caused by adverse insulin administration is commonly achieved by measuring blood glucose and insulin levels and, when indicated, C-peptide concentration.…”

Anakinra and Tocilizumab Enhance Survival and Function of Human Islets during Culture: Implications for Clinical Islet Transplantation

“…In the middle of 19 th century, the French doctor Claude Bernard discovered how liver play a role in glycogenesis and established that diabetes is due to excess production of glucose 3 . The young German medical student, Paul Langerhans described in his thesis Attempts to isolate the pancreatic extract failed until 1921 when Banting, Best and Collip discovered the pancreatic extract that they named insulin [7][8][9] . The first patient was treated with injection of insulin in 1922; it was a 14-year-old diabetic boy that was dying at the Toronto General…”

Die klinische Chemie – Herausforderung der Medizin für die analytische Chemie und die Nanowissenschaften

“…[4] Die Vorstellung, dass der Sitz der Krankheiten im Organ sei und deshalb die Anatomie des Organs studiert werden müsse, geht auf Arbeiten von Morgagni (1682-1771) zurück. [5] Der Chemiker und Mediziner de Fourcroy (1755-1809) bemühte sich, die Chemie in die Medizin zu integrieren. [6] Am Ende des 18.…”

“…[11] Die Möglichkeit der Quantifizierung von Analyten, dargestellt an der Entwicklung des Glucosenachweises im Urin (Tabelle 2), sowie weitere Fortschritte der Biochemie und der Aufbau neuer Laboratorien während des Ersten Weltkrieges gaben dem Fach neue Impulse. [5] Nach dem Zweiten Weltkrieg wurde die international einheitliche Bezeichnung "klinische Chemie" von der American Association of Clinical Chemists (AACC) und der IFCC eingeführt. [12] Jürgen Durner studierte Chemie an der Technischen Universität München und Humanmedizin an der Ludwig-Maximilians-Universität München (LMU…”